Published in Circ J on December 03, 2013
Exercise physiology in heart failure and preserved ejection fraction. Heart Fail Clin (2014) 0.86
Evidence of microvascular dysfunction in heart failure with preserved ejection fraction. Heart (2015) 0.81
Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade. Am J Physiol Heart Circ Physiol (2014) 0.80
Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction. Curr Opin Cardiol (2015) 0.76
Heterogeneous responses of systolic and diastolic left ventricular function to exercise in patients with heart failure and preserved ejection fraction. ESC Heart Fail (2015) 0.75
Ergospirometry and Echocardiography in Early Stage of Heart Failure with Preserved Ejection Fraction and in Healthy Individuals. Arq Bras Cardiol (2015) 0.75
Heart failure with preserved ejection fraction and skeletal muscle physiology. Heart Fail Rev (2017) 0.75
Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction. Front Endocrinol (Lausanne) (2017) 0.75